Phase I Cancer Clinical Trials as Care Option Arrives in Hawaii Thanks to $6.5M from NIH

Sep 28, 2019 | Cancer, Clinical Research as a Care Option, Clinical Research Center, Oncology, University of Hawaii

The National Institutes of Health awarded the University of Hawaii Cancer Center $6.5 million to build a state-of-the-art clinical research center that will significantly improve access to investigational, Phase I clinical trial treatments for cancer patients. Now local Hawaii residents won’t have to travel all the way to the “Mainland” to access specialized, advanced investigational therapies for various cancers. The new center will be named Hoʻōla which means healing. Clinical research as a care option for cancer has arrived in the State of Hawaii.

Funding for the Clinical Research Center

As reported in the University of Hawaii News, the federal funds match the $6.5 million approved by the state Legislature this past session. The $13 million total will be utilized to build the Clinical Research Center, in 36,000 Square feet of existing shell space at the University of Hawaii Cancer Center in Kakaʻako.

Hawaii Readies for the Future Today

About 6,700 Hawaiians are diagnosed with cancer annually in the state. An estimated 100 to 200 patients will be served annually by the new center—offering hope for a population that would have had to travel to the Mainland. Many wouldn’t be able to afford the effort. Now with the imminent launch of the center, those that would have faced great financial, physical and emotional hardship of requiring travel halfway across the Pacific Ocean will have their very own world-class research center.

A Joint Venture

The new cancer center accommodating Early Phase Cancer Clinical Trials represents a joint venture of the University of Hawaii Cancer Center, the University of Hawaii and clinical partners in the Hawaii Cancer Consortium—including Hawaii Pacific Health, Kuakini Medical Center and the Queen’s Medical Center. Hawaii’s patient population struggling with various cancers will soon have potentially powerful options, including Phase I clinical trials for “complementary” and “value-added” cancer care.

Lead Research/Investigator

Randall Holcombe, UH Cancer Center Director

Call to Action: Are you a Hawaii resident struggling with a cancer diagnosis? If you haven’t been to the UH Cancer Center we recommend setting up an appointment for a second opinion.


Pin It on Pinterest